Bio101 signs agreement to partner with Stannards

Bio101 signs agreement to partner with Stannards

Bio101 is pleased to announce that we have signed an agreement to partner with Stannards, a boutique accounting, audit and advisory firm that works with mid-market businesses, private and family-owned companies, and family offices. Completion remains subject to regulatory approval and customary financial transaction closing conditions.

The proposed partnership would bring Bio101’s expertise in finance, governance and transaction advisory for life sciences and healthcare clients alongside Stannards’ broader advisory, specialist tax and R&D capabilities.

Clients should continue to contact their usual Bio101 or Stannards representative. We will confirm when completion occurs.

Media enquiries: Cameron Jones, Managing Director – Bio101  +61400086399 | cameron.jones@bio101.com

About Stannards – https://stannards.com.au/

Since 2016, we’ve provided our clients with financial advisory and governance support.

Since 2016, we’ve provided our clients with financial advisory and governance support.

Bio101 was established in 2016 with a view that there was an opportunity to provide a focused finance, company secretarial and transaction advisory service to the biotech and healthcare sector. Bio101 has had strong growth since 2016 with; four (4) executive directors, one (1) non-executive director (Chair) and approximately fifty (50) staff across three (3) states and two (2) countries.

Our growth has been driven by our strong reputation.

Our growth has been driven by our strong reputation.

Growth has been primarily organic, driven by the growing biotech and healthcare sector and word-of-mouth referrals. We have approximately 100 clients who are a mix of ASX listed, venture capital investee, companies seeking to list on the ASX, spin outs from universities and research institutes along with offshore entities establishing an Australian presence for the favourable clinical trial conditions and potential access to the R&D tax incentive.

We are starting to get noticed

We are starting to get noticed

Conversations with clients increasingly extend beyond traditional accounting and governance matters, with many seeking our perspective on market dynamics, AI adoption, business growth, and operational effectiveness.

Continuing to deliver.

Continuing to deliver.

Today, we have three key divisions – Finance, CoSec & Transaction Advisory – all of which form a complementary relationship in helping our client’s needs. At its heart we are about providing clients with financial advisory and governance support – thereby allowing our clients to focus on their R&D and business priorities.

Onto the next era - our second decade

Onto the next era - our second decade

Having set our roots down in Melbourne’s Eastern Suburbs across our first decade – In 2025 we shifted to a roomier and more modern premises in Hawthorn East, which will serve us for our second decade.

Bio101 -
“Hamish played a crucial role in securing a $5M investment from an important institutional investor, allowing us to accelerate our domestic and global expansion plans. Hamish and the Bio101 team provided comprehensive and valuable transactional support throughout the entire process”
Client - CEO